A Study to Compare Fluticasone /Formoterol Breath Actuated Inhaler (BAI) and Ultibro in Subjects With Fixed Airflow Obstruction and Elevated Eosinophils

NCT02693769 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Recruitment issues

Conditions

ACOS (Fixed Airflow Obstruction and Elevated Eosinophils)

Interventions

DRUG: fluticasone propionate/formoterol fumarate breath actuated inhaler
DRUG: Indacaterol maleate / glycopyrronium bromide capsules

Sponsor

Mundipharma Research Limited